Evidence map›Paper›PMID 30736829›Full record

ArticleJournal of experimental & clinical cancer research : CR2019

Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery.

Weihua Ren, Jianfeng Hou, Chenguang Yang, Hanjun Wang, Shuangting Wu, Yabin Wu, Xingpeng Zhao, Chao Lu

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 216 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
216citing papers in PubMed, 2 pooled it
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

216 citing papers in PubMed, 2 syntheses or guidelines pooled it, 335 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Metabolic Cross Talk in the Tumor Microenvironment.Cancer treatment and research · 2026
    Review
  18. Review
  19. Article
  20. Review

156 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Weihua RenMedical Examination Center, Luoyang Central Hospital, Zhengzhou University, No.288, Middle Zhongzhou Rd, Xigong District, Luoyang, 471009, China. hopeqiu86@163.com.
Jianfeng HouDepartment of Oncology, Zhengzhou Central Hospital, Zhengzhou, Henan, China.
Chenguang YangDepartment of Oncology, Kaifeng Central Hospital, Kaifeng, 475000, China.
Hanjun WangImaging Department of Luoyang Orthopedic-traumatological Hospital, Luoyang, 471000, China.
Shuangting WuDepartment of Anesthesiology, Luoyang Central Hospital, Zhengzhou University, Luoyang, 471009, China.
Yabin WuMedical Examination Center, Luoyang Central Hospital, Zhengzhou University, No.288, Middle Zhongzhou Rd, Xigong District, Luoyang, 471009, China.
Xingpeng ZhaoMedical Examination Center, Luoyang Central Hospital, Zhengzhou University, No.288, Middle Zhongzhou Rd, Xigong District, Luoyang, 471009, China.
Chao LuDepartment of Oncology, Zhengzhou Central Hospital, Zhengzhou, Henan, China.
Luoyang Central Hospital Affiliated to Zhengzhou University · CNZhengzhou Central Hospital · CNLuoyang Orthopedic-Traumatological Hospital of Henan Province · CN

Funding

Instituto de Pesquisa Translacional em Saúde e Ambiente na Região Amazônica 152300410007Molecular epidemiological study of early syphilis 162102310244
6 · The paper itself

Abstract

objectiveTo investigate the lung cancer-promoting mechanism of mesenchymal stem cell-secreted extracellular vesicles (MSC-EV).

methodsEV were isolated from culture media of human bone marrow-derived MSCs that were pre-challenged with or without hypoxia (referred to as H-EV and N-EV, respectively). After treatment with N-EV or H-EV, A549 and H23 cell proliferation, apoptosis, trans-well invasion and epithelial-to-mesenchymal transition (EMT) were examined. Polarization of human primary monocytes-derived macrophages with or without N-EV or H-EV induction were analyzed by flow cytometry and ELISA. PTEN, PDCD4 or RECK gene was overexpressed in A549 cells, while miR-21-5p was knocked down in MSCs, A549 or H23 lung cancer cells or primary monocytes by miR-21-5p inhibitor transfection. Protein level of PTEN, PDCD4, RECK, AKT or STAT3 as well as phosphorylation level of AKT or STAT3 protein were assayed by western blot. Tumorigenicity of A549 and H23 cells with or without MSC-EV co-injection was assayed on immunocompromised mice. The xenograft tumor were examined for cell proliferation, angiogenesis, apoptosis and intra-tumoral M1/M2 macrophage polarization.

resultsComparing to N-EV, H-EV treatment significantly increased A549 and H23 cell proliferation, survival, invasiveness and EMT as well as macrophage M2 polarization. MiR-21-5p knocked down significantly abrogated the cancer-promoting and macrophage M2 polarizing effects of H-EV treatment. H-EV treatment downregulated PTEN, PDCD4 and RECK gene expression largely through miR-21-5p. Overexpressing PTEN, PDCD4 and RECK in A549 cells significantly reduced the miR-21-5p-mediated anti-apoptotic and pro-metastatic effect of H-EV, while overexpressing PTEN in monocytes significantly reduced macrophage M2 polarization after induction with the presence of H-EV. H-EV co-injection significantly increased tumor growth, cancer cell proliferation, intra-tumoral angiogenesis and M2 polarization of macrophages in vivo partially through miR-21-5p.

conclusionsIncreased miR-21-5p delivery by MSC-EV after hypoxia pre-challenge can promote lung cancer development by reducing apoptosis and promoting macrophage M2 polarization.

Indexed as

AnimalsCarcinoma, Non-Small-Cell LungCell HypoxiaCell ProliferationExtracellular VesiclesHumansLung NeoplasmsMacrophagesMesenchymal Stem CellsMiceMicroRNAsMicroRNAsMIRN21 microRNA, humanExtracellular vesiclesHypoxiaLung cancerMacrophage polarizationMesenchymal stem cellsmiR-21-5p

Identifiers

PMID30736829
PMCPMC6367822
OpenAlexW2922323050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.